Related Experiment Video
Updated: Feb 16, 2026

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring
Published on: November 29, 2024
Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ?
Feras M Ghazawi1, Ramin Zargham, Mirko S Gilardino
1Feras M. Ghazawi, MD, PhD, MSc • Resident Physician • Division of Dermatology • University of Ottawa • Ottawa, Ontario, Canada • Faculty of Medicine • McGill University • Montreal, Quebec, Canada Ramin Zargham, MD, PhD • Selective Surgical Pathology Fellow • Roswell Park Cancer Institute • Buffalo, New York Mirko S. Gilardino, MD, MSc • Plastic Surgeon • Division of Plastic and Reconstructive Surgery • McGill University Health Centre • Montreal, Quebec, Canada Denis Sasseville, MD • Dermatologist • Division of Dermatology • McGill University Health Centre • Montreal, Quebec, Canada Fatemeh Jafarian, MD • Dermatologist • Division of Dermatology • McGill University Health Centre • Montreal, Quebec, Canada.
General Purpose:
To provide information about the clinical presentation of hypertrophic scars and keloids based on their varied structural components.
Target Audience:
This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and nurses with an interest in skin and wound care.
Learning Objectives/Outcomes:
After completing this continuing education activity, you should be able to: ABSTRACT: Hypertrophic scars and keloids are firm, raised, erythematous plaques or nodules that manifest when the cicatrix fails to properly heal. They result from pathologic wound healing and often cause pain and decreased quality of life. The appearance of such cosmetically unappealing scars affects the confidence and self-esteem of many patients. These scars can also cause dysfunction by interfering with flexion and extension across joints. Both possess some unique and distinct histochemical and physiologic characteristics that set them apart morphologically and at the molecular level. While these entities have been the focus of research for many years, differentiating between them remains challenging for clinicians.This article reviews the clinical presentation of aberrant scars and illustrates how they can be differentiated. It outlines their pathophysiology and emphasizes the unique molecular mechanisms underlying each disorder. It also examines how altered expression levels and the distribution of several factors may contribute to their unique clinical characteristics and presentation. Further research is needed to elucidate optimal treatments and preventive measures for these types of aberrant scarring.
Related Concept Videos
Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension II: Pathophysiology
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pathophysiology of Heart Failure
Clinical Applications of Epidermal Stem Cells

